Overall, these data suggest that the supplementation with collagen hydrolysate C-LMW promotes a partial amelioration of HFS-induced metabolic dysfunctions, particularly regarding glucose homeostasis and insulin sensitivity, though its effects on lipid metabolism appear modest or unclear. The gene discussed is INS; the disease is Hand-foot syndrome.